399 related articles for article (PubMed ID: 20466621)
21. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET).
Erdi YE; Rosenzweig K; Erdi AK; Macapinlac HA; Hu YC; Braban LE; Humm JL; Squire OD; Chui CS; Larson SM; Yorke ED
Radiother Oncol; 2002 Jan; 62(1):51-60. PubMed ID: 11830312
[TBL] [Abstract][Full Text] [Related]
22. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
[TBL] [Abstract][Full Text] [Related]
23. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.
Ciernik IF; Dizendorf E; Baumert BG; Reiner B; Burger C; Davis JB; Lütolf UM; Steinert HC; Von Schulthess GK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):853-63. PubMed ID: 14529793
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
25. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
[TBL] [Abstract][Full Text] [Related]
26. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
[TBL] [Abstract][Full Text] [Related]
27. Role of computed tomography and [18F] fluorodeoxyglucose positron emission tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.
Ceresoli GL; Cattaneo GM; Castellone P; Rizzos G; Landoni C; Gregorc V; Calandrino R; Villa E; Messa C; Santoro A; Fazio F
Tumori; 2007; 93(1):88-96. PubMed ID: 17455878
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
29. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma.
Moureau-Zabotto L; Touboul E; Lerouge D; Deniaud-Alexandre E; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Kerrou K; Montravers F; Keraudy K; Tiret E; Gendre JP; Grange JD; Houry S; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):340-5. PubMed ID: 16168829
[TBL] [Abstract][Full Text] [Related]
30. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol.
Berson AM; Stein NF; Riegel AC; Destian S; Ng T; Tena LB; Mitnick RJ; Heiba S
Med Dosim; 2009; 34(1):30-5. PubMed ID: 19181253
[TBL] [Abstract][Full Text] [Related]
31. Perfusion magnetic resonance imaging in contouring of glioblastoma patients: Preliminary experience from a single institution.
Munshi A; Ganesh T; Gupta RK; Vaishya S; Patir R; Sarkar B; Khataniar N; Bansal K; Rastogi K; Mohanti BK
J Cancer Res Ther; 2020; 16(6):1488-1494. PubMed ID: 33342818
[TBL] [Abstract][Full Text] [Related]
32. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
[TBL] [Abstract][Full Text] [Related]
33. Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies.
Geets X; Daisne JF; Tomsej M; Duprez T; Lonneux M; Grégoire V
Radiother Oncol; 2006 Mar; 78(3):291-7. PubMed ID: 16499982
[TBL] [Abstract][Full Text] [Related]
34. Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT.
Niyazi M; Landrock S; Elsner A; Manapov F; Hacker M; Belka C; Ganswindt U
Radiat Oncol; 2013 Jul; 8():180. PubMed ID: 23848981
[TBL] [Abstract][Full Text] [Related]
35. Comparison of CT and integrated PET-CT based radiation therapy planning in patients with malignant pleural mesothelioma.
Pehlivan B; Topkan E; Onal C; Nursal GN; Yuksel O; Dolek Y; Yavuz MN; Yavuz AA
Radiat Oncol; 2009 Sep; 4():35. PubMed ID: 19758456
[TBL] [Abstract][Full Text] [Related]
36. PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.
Kornerup JS; Brodin NP; Björk-Eriksson T; Birk Christensen C; Kiil-Berthelsen A; Aznar MC; Hollensen C; Markova E; Munck Af Rosenschöld P
Br J Radiol; 2015 Mar; 88(1047):20140586. PubMed ID: 25494657
[TBL] [Abstract][Full Text] [Related]
37. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
38. Comparison of CT and positron emission tomography/CT coregistered images in planning radical radiotherapy in patients with non-small-cell lung cancer.
Macmanus M; D'Costa I; Everitt S; Andrews J; Ackerly T; Binns D; Lau E; Ball D; Weih L; Hicks RJ
Australas Radiol; 2007 Aug; 51(4):386-93. PubMed ID: 17635480
[TBL] [Abstract][Full Text] [Related]
39. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
[TBL] [Abstract][Full Text] [Related]
40. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.
Leong T; Everitt C; Yuen K; Condron S; Hui A; Ngan SY; Pitman A; Lau EW; MacManus M; Binns D; Ackerly T; Hicks RJ
Radiother Oncol; 2006 Mar; 78(3):254-61. PubMed ID: 16545881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]